Analog Devices, Inc. (NASDAQ: ADI) is a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. ADI combines analog, digital, and software technologies into solutions that help drive advancements in digitized factories, mobility, and digital healthcare, combat climate change, and reliably connect humans and the world. With revenue of more than $12 billion in FY23 and approximately 26,000 people globally working alongside 125,000 global customers, ADI ensures today’s innovators stay Ahead of What’s Possible. Learn more at www.analog.com

Bose Corporation was founded in 1964 by Dr. Amar G. Bose, then a professor of electrical engineering at the Massachusetts Institute of Technology. Today, the company is driven by its founding principles, investing in long-term research with one fundamental goal: to develop new technologies with real customer benefits. Bose innovations have spanned decades and industries, creating and transforming categories in audio and beyond. Bose products for the home, in the car, on the go and in public spaces have become iconic, changing the way people listen to music. 832029-0010B

Axcelis Technologies, Inc. is a world-leading provider of equipment and services to the semiconductor manufacturing industry. For over forty five years, chipmakers from around the globe have relied on Axcelis'​ tools and process expertise to form the transistors that power all electronics - from smartphones and laptops, cameras, personal music players and more. Our equipment portfolio comprises a powerful suite of manufacturing technologies for ion implantation, one of the most critical steps in the IC manufacturing process. In addition, we provide extensive aftermarket service and support, including spare parts, equipment upgrades, maintenance services, and customer training. Our customers include all of the 20 largest semiconductor manufacturers in the world. More than 3000 of our products are in use worldwide. At our Advanced Technology Center in Beverly, Mass., we collaborate with customers and other industry experts to develop next-generation applications and process capabilities. We support our customers with a worldwide network of 38 field offices in 10 countries. In all that we do, our strategy is singular: align every Axcelis innovation and success with our customers'​ goals. We strive to understand the entirety of their challenges and stand ready to deliver the technology, service and support they need to succeed.

We help media visionaries create art that colors our perceptions and enriches our culture. We make innovative technology and collaborative tools that inspire and spark joy so creators can entertain, inform, educate and enlighten the world. We believe in our artists. We believe in our industry leaders. And we believe in the future of entertainment. We have a rich, 30-year history of powering media and entertainment. But we know our history doesn’t determine our future, so we are always evolving, committed to making good better and better best. We make many products, but we only do one thing: maximize the mediums of amazing makers. At Avid, every minute, of every day, we are powering greater creators.

Nova Biomedical is a company dedicated to using advanced technology to develop better blood testing analyzers for medical use. These products are called in vitro diagnostic devices (IVD). We use some of the same advanced technology to provide the biotechnology industry with innovative instruments for cell culture monitoring. Nova is the largest privately owned IVD company in the U.S. and the third largest in the world, with over 1,200 employees globally. Our eight percent compounded annual growth over nearly a decade is more than double the IVD market growth, making Nova one the fastest growing IVD companies in the world. Corporate Commitment to Quality Nova’s size and rapid growth are the result of customers throughout the world responding to the exceptional quality and value of Nova’s technology, products, and customer service. Our strong corporate commitment to these three areas has made Nova a world leader in clinical, veterinary, and biotechnology chemistry testing analyzers. A Leader in Medical Science Technology Maintaining leadership in any technology industry requires a long-term perspective and commitment to research and development. Nova Biomedical has consistently invested more than 10 percent of sales into research and development — more than double the industry average. Our investment in research and development provides a continuous product pipeline of new and better technology products for our customers. Working at Nova Biomedical We practice our core values of mutual respect, honesty, and integrity throughout Nova. With a strong sense of family in the workplace, we are proud that one third of all our employees have been with us for over 10 years.

We are guided by the scientific spirit. Innovation and exploration are at the heart of what we do. Discover what sets us apart.